Home > Insider Trading > Filing (0001209191-10-018428)

Filing Details

Accession Number:: 0001209191-10-018428
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2010-03-23 13:00:00
Reporting Period:: 2010-03-19

Filing Date:: 2010-03-23
Accepted Time:: 2010-03-23 19:06:39
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1254419	Medassets Inc	MDAS	Services-Prepackaged Software (7372)	510391128

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1034486	P L Iii Partners Galen	C/O Galen Management, L.l.c. 680 Washington Blvd. Stamford CT 06901	No	No	Yes	No
1034574	P L Iii International Partners Galen	C/O Galen Management, L.l.c. 680 Washington Blvd. Stamford CT 06901	No	No	Yes	No
1056642	Galen Employee Fund Iii Lp	C/O Galen Management, L.l.c 680 Washington Blvd. Stamford CT 06901	No	No	Yes	No
1056643	Claudius Llc	C/O Galen Management, L.l.c 680 Washington Blvd. Stamford CT 06901	No	No	Yes	No
1203341	Galen Partners Iv Lp	C/O Galen Management, L.l.c. 680 Washington Blvd. Stamford CT 06901	No	No	Yes	No
1424567	Galen Employee Fund Iv, L.p.	C/O Galen Management, L.l.c 680 Washington Blvd. Stamford CT 06901	No	No	Yes	No
1424569	Galen Partners International Iv, L.p.	C/O Galen Management, L.l.c 680 Washington Blvd. Stamford CT 06901	No	No	Yes	No
1425527	Claudius Iv, Llc	C/O Galen Management, L.l.c 680 Washington Blvd. Stamford CT 06901	No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2010-03-19	2,000	$22.12	5,857,572	No	4	S	Indirect	See FN
Common Stock	Disposition	2010-03-22	40,273	$22.13	5,817,299	No	4	S	Indirect	See FN
Common Stock	Disposition	2010-03-23	100	$22.06	5,817,199	No	4	S	Indirect	See FN

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	See FN
No	4	S	Indirect	See FN
No	4	S	Indirect	See FN

Footnotes

The sale of shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Funds on September 1, 2009
The shares were sold as follows: 352 shares by Galen Partners IV, L.P. ("Galen IV"), 28 shares by Galen Partners International IV, L.P. ("Galen International IV"), 1 share by Galen Employee Fund IV, L.P. ("Employee Fund IV"), 1,480 shares by Galen Partners III, L.P. ("Galen III"), 134 shares by Galen Partners International III, L.P. ("Galen International III") and 5 shares by Galen Employee Fund III, L.P. ("Employee Fund III" and, collectively with Galen IV, Galen International IV, Employee Fund IV, Galen III, Galen International III, the "Funds").
The shares are held as follows: 1,029,717 by Galen IV, 81,797 by Galen International IV, 1,435 by Employee Fund IV, 4,333,349 by Galen III, 392,717 by Galen International III and 18,557 by Employee Fund III. Claudius IV, L.L.C. ("Cladius IV") serves as the sole General Partner of Galen IV and Galen International IV and has sole voting and investment control over the shares held by such funds and may be deemed to beneficially own the shares held by such funds. Wesson Enterprises, Inc. serves as the sole General Partner of Employee Fund IV and Employee Fund III and has sole voting and investment control over the shares held by such funds and may be deemed to beneficially own the shares held by such funds.
Claudius, L.L.C. serves as the sole General Partner of Galen III and Galen International III and has sole voting and investment control over the shares held by such funds and may be deemed to beneficially own the shares held by such funds. Each of the Reporting Persons disclaims beneficial ownership of the shares reported herein, except to the extent of its respective pecuniary interest therein.
The shares were sold as follows: 7,084 shares by Galen IV, 563 shares by Galen International IV, 10 shares by Employee Fund IV, 29,811 shares by Galen III, 2,702 shares by Galen International III and 103 shares by Employee Fund III.
The shares were sold at prices between $22.06 and $22.37. The Reporting Entities will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
The shares are held as follows: 1,022,633 by Galen IV, 81,234 by Galen International IV, 1,425 by Employee Fund IV, 4,303,538 by Galen III, 390,015 by Galen International III and 18,454 by Employee Fund III. Claudius IV serves as the sole General Partner of Galen IV and Galen International IV and has sole voting and investment control over the shares held by such funds and may be deemed to beneficially own the shares held by such funds. Wesson Enterprises, Inc. serves as the sole General Partner of Employee Fund IV and Employee Fund III and has sole voting and investment control over the shares held by such funds and may be deemed to beneficially own the shares held by such funds.
The shares were sold as follows: 18 shares by Galen IV, 1 share by Galen International IV, 74 shares by Galen III and 7 shares by Galen International III.
The shares are held as follows: 1,022,615 by Galen IV, 81,233 by Galen International IV, 1,425 by Employee Fund IV, 4,303,464 by Galen III, 390,008 by Galen International III and 18,454 by Employee Fund III. Claudius IV serves as the sole General Partner of Galen IV and Galen International IV and has sole voting and investment control over the shares held by such funds and may be deemed to beneficially own the shares held by such funds. Wesson Enterprises, Inc. serves as the sole General Partner of Employee Fund IV and Employee Fund III and has sole voting and investment control over the shares held by such funds and may be deemed to beneficially own the shares held by such funds.